FDA Brief

Warning letters Drugs

FDA warning letter to

Glenmark Pharmaceuticals Limited

Issued Nov 22, 2022Posted Dec 6, 2022Center for Drug Evaluation and Research | CDER

CGMP/Finished Pharmaceuticals/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Glenmark Pharmaceuticals Limited's FDA history

  1. Glenmark Pharmaceuticals Limited

    FDA warns Glenmark over unresolved dissolution failures and inadequate investigations at its Pithampur, India drug plant.

    High risk

Full company page